A study by Brown University Health researchers has identified a crucial factor that may help improve treatment for ...

The A.M.A.’s announcement followed a similar recommendation from the American Society of Plastic Surgeons. Other medical groups argued for a more personalized approach.

Recent trials reveal promising advancements in targeted therapies for chondrosarcomas and tenosynovial giant cell tumors.

The FDA grants Fast Track designation to sonelokimab for moderate to severe palmoplantar pustulosis, a chronic inflammatory skin disease.

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

As the management landscape of primary biliary cholangitis (PBC) changes, new second-line options offer effective alternatives for patients who respond inadequately to standard first-line treatment ...

Brendan Saloner ([email protected]), Brown University, Providence, Rhode Island. Pooja Lagisetty, University of Michigan, Ann Arbor, Michigan. Access and scale are two sides of the same coin. Whereas ...

New research suggests the targeted radiation treatment may reduce long-term side effects while maintaining strong cancer ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of ...

Menopause clinics across the U.S. are hearing from women who are having trouble filling prescriptions for estrogen patches, a common hormone replacement therapy.

Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of liver disease worldwide, affecting one in three people.1,2 The inflammatory form of MASLD, namely ...